Question 1

What does Albany Molecular Research do?

Accepted Answer

“Albany Molecular Research Inc. provides scientific services, products and technologies that improve quality of life while delivering

Question 2

In what sectors does Albany Molecular Research operate?

Accepted Answer

Albany Molecular Research operates in Biotechnology, Manufacturing, Pharmaceutical.

Question 3

How many companies has Albany Molecular Research acquired?

Accepted Answer

Albany Molecular Research has made 12 acquisitions between 2001-2021, with a total disclosed deal value of $739.4M.

Question 4

What companies are owned by Albany Molecular Research?

Accepted Answer

Companies acquired by Albany Molecular Research include LakePharma, Integrity Bio, Euticals, Whitehouse Laboratories, Gadea Pharmaceutical Group, Oso Biopharmaceuticals Manufacturing, Cedarburg Hauser Pharmaceuticals, Excelsyn, and 4 more.

Question 5

What are Albany Molecular Research's major acquisitions?

Accepted Answer

Albany Molecular Research's largest acquisitions include Euticals ($358.0M, 2016), Gadea Pharmaceutical Group ($174.0M, 2015), Oso Biopharmaceuticals Manufacturing ($110.0M, 2014), Cedarburg Hauser Pharmaceuticals ($41.0M, 2014).

Question 6

What is Albany Molecular Research's largest acquisition?

Accepted Answer

Albany Molecular Research's largest disclosed acquisition is Euticals for $358.0M (2016).

Question 7

What was Albany Molecular Research's first acquisition?

Accepted Answer

Albany Molecular Research's first recorded acquisition was Bothell Research Center in 2001 for $22.4M.

Question 8

What was Albany Molecular Research's most recent acquisition?

Accepted Answer

Albany Molecular Research's most recent acquisition is LakePharma, announced July 2021.

Question 9

What is the average deal size for Albany Molecular Research acquisitions?

Accepted Answer

The average disclosed deal size for Albany Molecular Research acquisitions is $105.6M.

Question 10

What is the median deal size for Albany Molecular Research acquisitions?

Accepted Answer

The median disclosed deal size for Albany Molecular Research acquisitions is $41.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Albany Molecular Research spent on acquisitions?

Accepted Answer

Albany Molecular Research has spent at least $739.4M across its disclosed acquisitions (of 12 total deals; some prices are undisclosed).

Question 12

Which sector has Albany Molecular Research spent the most on?

Accepted Answer

Albany Molecular Research has committed the most disclosed capital to Pharmaceutical companies — about $551.0M across its deals in that sector.

Question 13

What sectors does Albany Molecular Research usually acquire in?

Accepted Answer

Albany Molecular Research most frequently acquires companies in Biotechnology, Pharmaceutical, Health Care.

Question 14

In which sector has Albany Molecular Research made the most acquisitions?

Accepted Answer

Albany Molecular Research has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Albany Molecular Research make the most acquisitions?

Accepted Answer

Albany Molecular Research made the most acquisitions in 2021, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Albany Molecular Research

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Albany Molecular Research

Acquisitions by Albany Molecular Research

Key People at Albany Molecular Research

Explore 200,000+ acquisitions — free

Recent News related to Albany Molecular Research

FAQs about Albany Molecular Research

People who checked this page also checked these